企業プロフィール

LENSAR 株価・ニュース・カタリスト

ティッカー:
LNSR
取引所:
NASDAQ
セクター:
Biopharma
所在地:
United States

株価パフォーマンス

8.44 USD (-3.21%)

終値

最終更新: 2026年8月20日

69.5M USD

時価総額

株価変動の要因

As of Aug 20, 2026, LNSR closed down 3.21% at $8.44. No new same-company headline was identified in the current news window.

企業概要

Robotic Cataract Technology

LENSAR develops advanced laser systems for cataract surgery. Its technology is intended to automate key surgical steps and help ophthalmic surgeons plan and execute precise, astigmatism-aware procedures.

ALLY System

The ALLY Robotic Cataract Laser System combines imaging, planning and femtosecond-laser capabilities in a compact platform designed for use in the operating room. LENSAR places systems with ophthalmic practices and surgery centers, then generates recurring revenue from procedure-linked consumables, service and upgrades.

今後のカタリスト

    最近のニュース

    1. 01
    2. 02
    3. 03
    4. 04
    5. 05

    類似銘柄

    事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。